Dhar et al. showed that miR-106a-5p expression is significantly associated with PCa progression and validated a PTEN tumor suppressor as a critical target of this oncomiR in PCa cells with a possibility of being used as a chemopreventive and predictive biomarker in the development of PCa [29]. This evidence concerns the gene PTEN and neoplasm.